# Dine Brands Global, Inc.: overview

DIN · NYSE · CIK 49754 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/din.md) · [Financials](/companies/din/financials.md) · [Filings](/companies/din/filings.md) · [Insiders](/companies/din/insiders.md)

Latest reported revenue: [$240.9m](/filings/0001628280-26-052924.md) for Q2 FY2026, three months to 2026-06-28, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-052924).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [195](/filings/0001628280-25-049239.md) | [205 d](/filings/0001628280-26-011393.md) | [215](/filings/0001628280-26-030905.md) | [231](/filings/0001628280-26-052924.md) | [216](/filings/0001628280-25-049239.md) | [218 d](/filings/0001628280-26-011393.md) | [225](/filings/0001628280-26-030905.md) | [241](/filings/0001628280-26-052924.md) |
| Gross margin | % | [47.8%](/filings/0001628280-25-049239.md) | [41.7% d](/filings/0001628280-26-011393.md) | [42.0%](/filings/0001628280-26-030905.md) | [39.9%](/filings/0001628280-26-052924.md) | [39.1%](/filings/0001628280-25-049239.md) | [42.4% d](/filings/0001628280-26-011393.md) | [38.8%](/filings/0001628280-26-030905.md) | [37.9%](/filings/0001628280-26-052924.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [9.8%](/filings/0001628280-25-049239.md) | [2.5% d](/filings/0001628280-26-011393.md) | [3.8%](/filings/0001628280-26-030905.md) | [6.0%](/filings/0001628280-26-052924.md) | [3.4%](/filings/0001628280-25-049239.md) | [(5.6%) d](/filings/0001628280-26-011393.md) | [3.3%](/filings/0001628280-26-030905.md) | [1.8%](/filings/0001628280-26-052924.md) |
| Diluted EPS | $ per share | [1.24](/filings/0001628280-25-049239.md) | not reported | [0.53](/filings/0001628280-26-030905.md) | [0.89](/filings/0001628280-26-052924.md) | [0.48](/filings/0001628280-25-049239.md) | not reported | [0.57](/filings/0001628280-26-030905.md) | [0.35](/filings/0001628280-26-052924.md) |
| Free cash flow | $m | [22.0 d](/filings/0001628280-25-049239.md) | [26.7 d](/filings/0001628280-26-011393.md) | [12.8](/filings/0001628280-26-030905.md) | [31.0 d](/filings/0001628280-26-052924.md) | [18.2 d](/filings/0001628280-25-049239.md) | [(8.6) d](/filings/0001628280-26-011393.md) | [(4.6)](/filings/0001628280-26-030905.md) | [1.3 d](/filings/0001628280-26-052924.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-29) | FY2025 (2025-12-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [896](/filings/0001628280-24-007397.md) | [909](/filings/0001628280-25-010259.md) | [831](/filings/0001628280-26-011393.md) | [812](/filings/0001628280-26-011393.md) | [879](/filings/0001628280-26-011393.md) |
| Gross margin | % | [41.9%](/filings/0001628280-24-007397.md) | [41.5%](/filings/0001628280-25-010259.md) | [47.7%](/filings/0001628280-26-011393.md) | [46.2%](/filings/0001628280-26-011393.md) | [40.9%](/filings/0001628280-26-011393.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [10.9%](/filings/0001628280-24-007397.md) | [8.9%](/filings/0001628280-25-010259.md) | [11.7%](/filings/0001628280-26-011393.md) | [8.0%](/filings/0001628280-26-011393.md) | [1.9%](/filings/0001628280-26-011393.md) |
| Diluted EPS | $ per share | [5.66](/filings/0001628280-24-007397.md) | [4.96](/filings/0001628280-25-010259.md) | [6.22](/filings/0001628280-26-011393.md) | [4.22](/filings/0001628280-26-011393.md) | [1.11](/filings/0001628280-26-011393.md) |
| Free cash flow | $m | [179](/filings/0001628280-24-007397.md) | [54.0](/filings/0001628280-25-010259.md) | [94.0](/filings/0001628280-26-011393.md) | [94.1](/filings/0001628280-26-011393.md) | [53.4](/filings/0001628280-26-011393.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/din/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $47.8m | 1,332,372 |  | Added +50,197 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $35.5m | 989,074 |  | Reduced −15,403 |
| [CIBC WORLD MARKET INC.](/funds/1421224.md) | 2026-06-30 | $25.2m | 702,291 |  | Reduced −211,163 |
| [HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND](/funds/1535845.md) | 2026-06-30 | $21.5m | 599,500 |  | New +599,500 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $19.4m | 540,048 |  | Added +11,839 |
| [NOMURA HOLDINGS INC](/funds/1163653.md) | 2026-06-30 | $15.4m | 429,753 |  | Added +371,719 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $14.4m | 401,950 |  | Added +16,533 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $12.1m | 336,459 |  | Reduced −788 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $11.7m | 327,215 |  | Added +102,803 |
| [CastleKnight Management LP](/funds/1835751.md) | 2026-06-30 | $11.7m | 325,911 |  | Added +44,844 |

## Recent filings

[All 1,962 filings](/companies/din/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-04 | 08:15 ET | [8-K](/filings/0001193125-26-382825.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-382825 |
| 2026-08-27 | 07:00 ET | [8-K](/filings/0001193125-26-369514.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-369514 |
| 2026-08-05 | 07:30 ET | [10-Q](/filings/0001628280-26-052924.md) | Quarterly report, period 2026-06-28 | 0001628280-26-052924 |
| 2026-08-05 | 07:15 ET | [8-K](/filings/0001193125-26-333848.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-333848 |
| 2026-06-02 | 17:00 ET | [8-K](/filings/0001193125-26-253783.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-253783 |
| 2026-05-19 | 17:01 ET | [8-K](/filings/0001193125-26-231043.md) | 5.07 Shareholder vote results | 0001193125-26-231043 |
| 2026-05-14 | 08:15 ET | [8-K](/filings/0001193125-26-222891.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-222891 |
| 2026-05-06 | 15:20 ET | [8-K/A](/filings/0001193125-26-208752.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208752 |
| 2026-05-06 | 07:30 ET | [10-Q](/filings/0001628280-26-030905.md) | Quarterly report, period 2026-03-29 | 0001628280-26-030905 |
| 2026-05-06 | 07:15 ET | [8-K](/filings/0001193125-26-207550.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-207550 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 28, 2025](/filings/0001628280-26-011393.md), filed Feb 25, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-28, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/aa498ba8-c136-441b-9f59-7ce46906ea59)

## About the filer

- CIK: 49754
- Tickers: DIN
- Exchange: NYSE
- SIC code: 5812 Retail-Eating  Places
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 17:26 ET. No prices; not investment advice.